Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2015 Jun;125(6):1321-1329.
doi: 10.1097/AOG.0000000000000863.

Use of cell-free DNA in the investigation of intrauterine fetal demise and miscarriage

Cecily A Clark-Ganheart  1 , Melissa H Fries, Kathryn M Leifheit, Taylor J Jensen, Nilda L Moreno-Ruiz, Peggy P Ye, Jacky M Jennings, Rita W Driggers
Affiliations
Clinical Trial

Use of cell-free DNA in the investigation of intrauterine fetal demise and miscarriage

Cecily A Clark-Ganheart et al. Obstet Gynecol. 2015 Jun.

Abstract

Objective: To estimate whether cell-free DNA is present in nonviable pregnancies and thus can be used in diagnostic evaluation in this setting.

Methods: We conducted a prospective cohort study of 50 participants at MedStar Washington Hospital Center, Washington, DC, between June 2013 and January 2014. Included were women with pregnancies complicated by missed abortion or fetal demise. All gestational ages were considered for study participation. Participants with fetal demise were offered the standard workup for fetal death per the American College of Obstetricians and Gynecologists. Maternal blood samples were processed to determine the presence of cell-free DNA, the corresponding fetal fractions, and genetic abnormalities.

Results: Fifty samples from nonviable pregnancies were analyzed. The average clinical gestational age was 16.9 weeks (standard deviation 9.2). The mean maternal body mass index was 30.3 (standard deviation 9.1). Seventy-six percent (38/50) of samples yielded cell-free DNA results, that is, had fetal fractions within the detectable range of 3.7-65%. Among the 38, 76% (29) were classified as euploid, 21% (8) as trisomies, and 3% (1) as microdeletion. A cell-free DNA result was obtained more frequently at ultrasonographic gestational ages of 8 weeks or greater compared with less than 8 weeks (87.9% [n=29/33, 95% confidence interval (CI) 72.7-95.2; and 52.9%, n=9/17, 95% CI 31.0-73.8] of the time, respectively, P=.012). Time from demise was not associated with obtaining a result.

Conclusion: Among nonviable pregnancies, cell-free DNA is present in the maternal plasma with fetal fractions greater than 3.7% in more than three fourths of cases after an ultrasonographic gestational age of 8 weeks.

Clinical trial registration: ClinicalTrials.gov, www.clinicaltrials.gov, NCT01916928.

Level of evidence: III.

PubMed Disclaimer

References

    1. Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, et al.. Presence of fetal DNA in maternal plasma and serum. Lancet 1997;350:485–7.
    1. Hooks J, Wolfberg AJ, Wang ET, Struble CA, Zahn J, Juneau K, et al.. Non-invasive risk assessment of fetal sex chromosome aneuploidy through directed analysis and incorporation of fetal fraction. Prenat Diagn 2014;34:496–9.
    1. Lim JH, Kim MH, Han YJ, Lee da E, Park SY, Han JY, et al.. Cell-free fetal DNA and cell-free total DNA levels in spontaneous abortion with fetal chromosomal aneuploidy. PLoS One 2013;8:e56787.
    1. Wilcox AJ, Weinberg CR, O'Connor JF, Baird DD, Schlatterer JP, Canfield RE, et al.. Incidence of early loss of pregnancy. N Engl J Med 1988;319:189–94.
    1. MacDorman MF, Kirmeyer S. Fetal and perinatal mortality, United States, 2005. Natl Vital Stat Rep 2009;57:1–19.

Publication types

Associated data